
Director, Process Lead - Integrated Planning and Capacity Management
AstraZeneca
Summary
AstraZeneca is building a scalable, integrated planning capability to support the growth of our Cell Therapy portfolio from clinical development through launch and commercialization. The Director, Process Lead, Integrated Planning & Capacity Management is the single accountable owner for the global process family that connects Sales & Operations Execution (S&OE), Sales & Operations Planning (S&OP), Network Strategy Planning, capacity management and slot management across Cell Therapy. This role owns how the process is designed, governed, measured, controlled and continuously improved.
Job description
About the Role
AstraZeneca is building a scalable, integrated planning capability to support the growth of our Cell Therapy portfolio from clinical development through launch and commercialization. The Director, Process Lead, Integrated Planning & Capacity Management is the single accountable owner for the global process family that connects Sales & Operations Execution (S&OE), Sales & Operations Planning (S&OP), Network Strategy Planning, capacity management and slot management across Cell Therapy. This role owns how the process is designed, governed, measured, controlled and continuously improved.
The Process Lead does not run each planning cycle, develop the network strategy or make individual slot-allocation decisions. Instead, the role establishes the common process architecture, decision rights, standards, interfaces, controls, capabilities and digital requirements that enable operational leaders to deliver consistent business outcomes across autologous, allogeneic and in-vivo modalities.
Key Accountabilities
End-to-End Process Ownership and Governance
- Own the global process architecture for integrated planning and capacity management, including S&OE, S&OP, the Network Strategy Planning process, capacity planning and slot management.
- Define process scope, standards, planning horizons, decision rights, governance forums, escalation pathways and interfaces across strategic, tactical and execution planning.
- Establish and lead the cross-functional process network, engaging operational process leads, Finance, Commercial, Clinical, Manufacturing, Quality, Patient Supply, Network Strategy and other stakeholders.
- Ensure the process design distinguishes process ownership from operational execution and clearly assigns accountability for planning outcomes, analytical outputs and business decisions.
- Maintain controlled process documentation, RACI models, business rules and process maps and ensure changes are assessed, approved, communicated and embedded.
Process Design, Integration and Maturity
- Design the end-to-end flow of assumptions, demand, supply, capacity, scenarios, constraints, decisions and feedback across S&OE, S&OP and Network Strategy Planning.
- Own the business-process design for capacity and slot management, including allocation principles, decision thresholds, escalation rules, interfaces and performance measures.
- Define the minimum analytical and information standards required to support scenario evaluation and cross-functional decisions.
- Assess process maturity, identify gaps and maintain a multiyear roadmap that moves the organization from fragmented and reactive practices toward standardized, integrated and exception-based planning.
- Benchmark Cell Therapy planning practices against AstraZeneca enterprise standards and external frameworks such as ASCM/APICS and Gartner.
Performance, Controls and Compliance
- Own the process performance framework and KPI definitions, with measures covering plan quality, service, capacity utilization, slot performance, decision effectiveness, adherence and process health.
- Establish process controls, confirmation mechanisms and periodic reviews to verify adoption, consistency and effectiveness across functions, sites and modalities.
- Ensure the process complies with applicable GxP, data-integrity, quality, financial and business-control requirements.
- Use performance data, recurring exceptions and user feedback to identify systemic issues and sponsor corrective and preventive improvements.
- Support audit and inspection readiness for process documentation, controls, training and evidence where applicable.
Digital Enablement and Change
- Translate process strategy and business outcomes into prioritized technology, data, analytics and automation requirements in partnership with the Process Leads, Planning Technology.
- Act as the business-process sponsor for relevant planning capabilities in OMP, SAP and connected tools, ensuring technology enables the approved process rather than embedding unnecessary complexity.
- Approve process requirements and business acceptance criteria for major capability releases and ensure benefits are measured after implementation.
- Lead change management, stakeholder engagement, communications and capability building required to adopt common processes and ways of working.
- Develop process stewards and subject-matter experts who can sustain and improve the process across the network.
Qualifications and Skills
Essential
- Bachelor's degree in Supply Chain, Engineering, Life Sciences, Business or a related field.
- 12+ years of progressive experience in supply chain planning, operations or process excellence within pharmaceutical, biotechnology or another complex regulated environment.
- Demonstrated experience designing, governing or transforming enterprise planning processes such as IBP, S&OP, S&OE, capacity planning or network planning.
- Strong understanding of planning hierarchies, scenario planning, demand-supply balancing, capacity management, master scheduling and execution interfaces.
- Experience establishing process governance, decision rights, KPIs, controls, process networks and continuous-improvement roadmaps.
- Proven ability to influence Directors and Senior Directors across global, matrixed functions without direct authority.
- Experience translating business-process requirements into digital planning capabilities and leading enterprise change.
Desirable
- Cell and gene therapy or other patient-specific, time-critical supply-chain experience.
- Experience with slot management, scarce-capacity allocation or treatment-center capacity models.
- Experience with OMP, SAP IBP, Kinaxis, o9 or comparable advanced-planning platforms.
- Lean/Six Sigma and/or ASCM certification such as CPIM or CSCP.
- Experience supporting clinical-to-commercial transition, launch readiness or network investment decisions.
Key Competencies
Enterprise process leadership; systems thinking; strategic influence; process architecture; decision-right design; change leadership; data fluency; structured problem-solving; stakeholder management; and a patient-first mindset.
Requirements
- Bachelor's degree in Supply Chain, Engineering, Life Sciences, Business or a related field
- 12+ years of progressive experience in supply chain planning, operations or process excellence within pharmaceutical, biotechnology or another complex regulated environment
- Demonstrated experience designing, governing or transforming enterprise planning processes such as IBP, S&OP, S&OE, capacity planning or network planning
- Strong understanding of planning hierarchies, scenario planning, demand-supply balancing, capacity management, master scheduling and execution interfaces
- Experience establishing process governance, decision rights, KPIs, controls, process networks and continuous-improvement roadmaps
- Proven ability to influence Directors and Senior Directors across global, matrixed functions without direct authority
- Experience translating business-process requirements into digital planning capabilities and leading enterprise change
Benefits
- Retirement Programs
- Paid Time Off
- Health, Dental & Vision
- Short-Term Incentive Bonuses
- Equity-Based Awards
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.